Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ali Anjam-Najmedini"'
Autor:
Ali Anjam-Najmedini, Rohollah Vahabpour, Ava Safaroghli-Azar, Alireza Kazemi, Parvaneh Movahhed, Majid Momeny, Davood Bashash
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 12, Iss 3, Pp 613-622 (2022)
Purpose: Although the complex structure of acute lymphoblastic leukemia (ALL) andinvolvement of diverse pathways in its pathogenesis have put an obstacle in the way of efficienttreatments, identification of strategies to manipulate the genome of neop
Externí odkaz:
https://doaj.org/article/3622dda1313445b79568127591ec090e
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 39:208-219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b24eb7ecfe790ac6550fc359b3e00d6b
https://doi.org/10.1007/s12288-022-01573-7
https://doi.org/10.1007/s12288-022-01573-7
Autor:
Parvaneh Movahhed, Atieh Pourbagheri-Sigaroodi, Ali Anjam-Najmedini, Ruhollah Vahabpour, Faranak Kazerouni
Publikováno v:
International Journal of Cancer Management. 15
Background: Gastric cancer (GC) is one of the most common malignancies worldwide. An in-depth understanding of the molecular mechanisms that underlies tumor GC will lead to breakthroughs in the targeted treatment of GC. Based on multiple lines of evi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4373e46499486a8e1dbd0c86f0cef781
https://doi.org/10.5812/ijcm-118185
https://doi.org/10.5812/ijcm-118185
Autor:
Ali Anjam-Najmedini, Parvaneh Movahhed, Majid Momeny, Davood Bashash, Ava Safaroghli-Azar, Rohollah Vahabpour, Alireza Kazemi
Publikováno v:
Advanced Pharmaceutical Bulletin. 12:613-622
Purpose: Although the complex structure of acute lymphoblastic leukemia (ALL) andinvolvement of diverse pathways in its pathogenesis have put an obstacle in the way of efficienttreatments, identification of strategies to manipulate the genome of neop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97681d927db311107daa69250d4d8f20
https://doi.org/10.34172/apb.2022.064
https://doi.org/10.34172/apb.2022.064
Autor:
Mansoureh Ajami, Monireh Ajami, Mahin Nikougoftar Zarif, Narjes Yazdi, Rezvan Tavakoli, Mohammadreza Sadri, Ali Anjam-Najmedini, Mohammad Houshmand, Amir Atashi, Mohammad Ojaghi, Alireza Kazemi
Publikováno v:
Anti-Cancer Drugs. 29:944-955
Although recent studies have reported different aspects of autophagy, from pro-survival to pro-death roles of this process in malignant cells, the underlying mechanisms by which autophagy inhibitors contribute toward the induction of programmed cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09cc6e15178ff7ea756acbcf8c18ddff
https://doi.org/10.1097/cad.0000000000000668
https://doi.org/10.1097/cad.0000000000000668
Autor:
Alireza Kazemi, Mahin Nikougoftar Zarif, Amir Atashi, Narjes Yazdi, Ali Anjam Najmedini, Mohammad Houshmand
Publikováno v:
Volume: 42, Issue: 5 405-413
Turkish Journal of Biology
Turkish Journal of Biology
Emerging evidence shows that long noncoding RNAs (lncRNAs) participate in various cellular processes, and that plasmacytoma variant translocation 1 (PVT1), a newly described oncogene that interacts with various molecules such as p15, p16, NOP2, and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::379a213faa2ef81d6296b3cf9741fc53
https://doi.org/10.3906/biy-1801-46
https://doi.org/10.3906/biy-1801-46
Autor:
Mohammad Houshmand, Alireza Kazemi, Ali Anjam Najmedini, Muhammad Shahzad Ali, Valentina Gaidano, Alessandro Cignetti, Carmen Fava, Daniela Cilloni, Giuseppe Saglio, Paola Circosta
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 5805, p 5805 (2021)
Journal of Clinical Medicine, Vol 10, Iss 5805, p 5805 (2021)
Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31792e8672177b25c437a03d681a7a27
https://doi.org/10.3390/jcm10245805
https://doi.org/10.3390/jcm10245805
Autor:
Ava, Safaroghli-Azar, Atieh, Pourbagheri-Sigaroodi, Davood, Bashash, Elaheh, Nooshinfar, Ali, Anjam-Najmedini, Soroush, Sadeghi, Mostafa, Rezaie-Tavirani, Mohammad Esmaeil, Akbari
Publikováno v:
International Journal of Molecular and Cellular Medicine
The advent of combination therapy unprecedentedly shifted the paradigm of cancer treatment by reconstructing the conventional protocols. By identifying the anti-tumoral activity for different natural products, recent interest has focused on inventing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28db9057c619e5e60229b5f86201af70
https://pubmed.ncbi.nlm.nih.gov/31565647
https://pubmed.ncbi.nlm.nih.gov/31565647